Sexual & Hormonal HealthA cross-sex, evidence-first overview of the peptides studied for sexual desire, arousal and erectile function — bremelanotide, kisspeptin, melanotan II and oxytocin — graded honestly for men and women. Only one is FDA-approved.
Sexual & Hormonal Health13 MIN READ
Sexual & Hormonal HealthA clinical-editorial ranking of the peptides studied for low sexual desire in women — bremelanotide (PT-141/Vyleesi), kisspeptin and oxytocin — graded honestly. Only one is FDA-approved, and even that is a modest, as-needed tool.
Sexual & Hormonal Health12 MIN READ
Sexual & Hormonal HealthA clinical-editorial ranking of the peptides studied for male low libido — PT-141, kisspeptin and gonadorelin — graded honestly. The strongest evidence for male desire is correcting low testosterone, not a peptide.
Sexual & Hormonal Health12 MIN READ
Sexual & Hormonal HealthA clinical-editorial ranking of the peptides studied for erectile dysfunction — melanocortin agents (PT-141, melanotan-2) and kisspeptin — graded honestly against the AUA first-line standard. No peptide is FDA-approved for ED.
Sexual & Hormonal Health12 MIN READ
Peptide EncyclopediaA clinical monograph on PT-141 (bremelanotide) — the centrally acting melanocortin agonist FDA-approved as Vyleesi for premenopausal HSDD. Grade-A human RCT data, a narrow label, and a real pressor and pigmentation safety profile.
Peptide Encyclopedia11 MIN READ